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The term rare diseases (RD) includes a wide heteroge-
neous group of disorders that can involve any human
organ or system. In the last decade RD have been incor-
porated into the agenda of health-care providers and
public-health authorities; however, many problems still
remain to be solved and even addressed properly. Some
of these issues refer to patient’ care and management
such as early diagnosis, quality of the information,
access to treatment and rehabilitation, and appropriate
multidisciplinary healthcare. Research is also necessary
as it is the way to learn about mechanisms of diseases,
improve diagnosis techniques and develop new thera-
peutic approaches. Research in psychological and social
aspects of RD is also needed. Determinants for biomedi-
cal research in RD and orphan medicines affect basic
science, clinical investigation, translational approaches,
and transfer activities at the pharmaceutical and biotech
companies, making the patient the focus of the triangle
made up of the academy, hospitals and industry.
These determinants can be summarised as follows: i)
The human factor: human resources for research need
to incorporate new research teams into the field of RD
and especially young scientists and physicians; ii) the
financial factor: funds from public agencies, national and
international, investment from the industry, and partici-
pation of charities and private foundations; iii) the train-
ing factor: interest in RD research has to be encouraged
in young people at the graduate school of medicine, bio-
logical sciences, public health, and healthcare profes-
sionals to promote the professional and research
interest; iv) core facilities: patients’ registries and bio-
banks; v) the healthcare system: reorganisation of health
resources and creation of centres of expertise to facili-
tate research into the clinical practice; vi) the social
factor: promotion and empowerment of patients and
their role as participants in clinical studies or clinical
trials; vii) the political factor: RD as a main topic for
public research.
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